Içli F, Dinçol D, Isikman E, Unal M
Medical Oncology Section, University of Ankara Medical School, Turkey.
J Surg Oncol. 1990 Aug;44(4):252-5. doi: 10.1002/jso.2930440412.
Twenty-three consecutive premenopausal patients with breast cancer who had four or more positive axillary nodes were treated with six cycles of CMFP followed by irradiation limited to the mastectomy scar (CT-SRT). The relapse-free survival (RFS) rate was compared with a group of 15 patients who were treated with chemotherapy alone (CT). Following an average follow-up of 30 months, the relapse rates for the CT-SRT and CT groups were 30.4% vs. 73.2%, respectively (P less than 0.05).
23例连续的绝经前乳腺癌患者，其腋窝淋巴结有4个或更多呈阳性，接受了6个周期的CMFP化疗，随后进行仅限于乳房切除瘢痕的照射（CT-SRT）。将无复发生存率（RFS）与15例仅接受化疗（CT）的患者组进行比较。平均随访30个月后，CT-SRT组和CT组的复发率分别为30.4%和73.2%（P<0.05）。
